Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial.
Yuerong JiangHaiyan GuoYue LiuXin WangJiaqi LiangRuixi XiRuina BaiDazhuo ShiPublished in: Trials (2019)
Chinese Clinical Trial Registry, ChiCTR-IPR-17011383 . Registered on 12 May 2017.